Vaccines Manufacturing and Innovation Centre

News

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale.

News

Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.